• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行第一波期间考纳斯医院医护人员中 SARS-CoV-2 的血清流行率。

SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.

机构信息

Department of Laboratory Medicine, The Hospital of Lithuanian University of Health Sciences Kauno Klinikos, 50161 Kaunas, Lithuania.

Department of Internal Medicine, Kaunas Hospital of Lithuanian University of Health Sciences, 47144 Kaunas, Lithuania.

出版信息

Medicina (Kaunas). 2021 Feb 6;57(2):148. doi: 10.3390/medicina57020148.

DOI:10.3390/medicina57020148
PMID:33562085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7915158/
Abstract

: Serologic testing is a useful additional method for the diagnosis of COVID-19. It is also used for population-based seroepidemiological studies. The objective of the study was to determine SARS-CoV-2 seroprevalence in healthcare workers of Kaunas hospitals and to compare two methods for specific SARS-CoV-2 antibody testing. : A total of 432 healthcare workers in Kaunas hospitals were enrolled in this study. Each participant filled a questionnaire including questions about their demographics, contact with suspected or confirmed COVID-19, acute respiratory symptoms, and whether they contacted their general practitioner, could not come to work, or had to be hospitalized. Capillary blood was used to test for SARS-CoV-2 specific immunoglobulin G (IgG) and immunoglobulin M (IgM) a lateral flow immunoassay. Serum samples were used to test for specific IgG and IgA class immunoglobulins using semiquantitative enzyme-linked immunosorbent assay (ELISA) method. : 24.77% of study participants had direct contact with a suspected or confirmed case of COVID-19. A total of 64.81% of studied individuals had at least one symptom representing acute respiratory infection, compatible with COVID-19. Lateral flow immunoassay detected SARS-CoV-2 specific IgG class immunoglobulins in 1.16% of the tested group. Fever, cough, dyspnea, nausea, diarrhea, headache, conjunctivitis, muscle pain, and loss of smell and taste predominated in the anti-SARS-CoV-2 IgG-positive group. Using ELISA, specific IgG were detected in 1.32% of the tested samples. Diarrhea, loss of appetite, and loss of smell and taste sensations were the most predominant symptoms in anti-SARS-CoV-2 IgG-positive group. The positive percent agreement of the two testing methods was 50%, and negative percent agreement was 99.66%. : 1.16% of tested healthcare workers of Kaunas hospitals were anti-SARS-CoV-2 IgG-positive. The negative percent agreement of the lateral flow immunoassay and ELISA exceeded 99%.

摘要

血清学检测是 COVID-19 诊断的一种有用的辅助方法。它也用于基于人群的血清流行病学研究。本研究的目的是确定考纳斯医院医护人员中 SARS-CoV-2 的血清流行率,并比较两种用于特定 SARS-CoV-2 抗体检测的方法。

本研究共纳入考纳斯医院的 432 名医护人员。每位参与者填写一份问卷,内容包括他们的人口统计学信息、与疑似或确诊 COVID-19 的接触情况、急性呼吸道症状以及是否联系过他们的全科医生、无法上班或需要住院等信息。使用毛细血管血检测 SARS-CoV-2 特异性免疫球蛋白 G(IgG)和免疫球蛋白 M(IgM),采用侧向流动免疫测定法。使用血清样本,采用半定量酶联免疫吸附试验(ELISA)方法检测特定 IgG 和 IgA 类免疫球蛋白。

研究参与者中有 24.77%与疑似或确诊 COVID-19 病例有直接接触。共有 64.81%的研究对象出现至少一种代表急性呼吸道感染的症状,与 COVID-19 相符。侧向流动免疫测定法在 1.16%的检测组中检测到 SARS-CoV-2 特异性 IgG 类免疫球蛋白。在抗 SARS-CoV-2 IgG 阳性组中,发热、咳嗽、呼吸困难、恶心、腹泻、头痛、结膜炎、肌肉疼痛以及嗅觉和味觉丧失占主导地位。使用 ELISA 检测到 1.32%的检测样本中存在特异性 IgG。在抗 SARS-CoV-2 IgG 阳性组中,腹泻、食欲不振和嗅觉味觉丧失是最主要的症状。两种检测方法的阳性符合率为 50%,阴性符合率为 99.66%。

考纳斯医院的 1.16%医护人员抗 SARS-CoV-2 IgG 呈阳性。侧向流动免疫测定法和 ELISA 的阴性符合率均超过 99%。

相似文献

1
SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.COVID-19 大流行第一波期间考纳斯医院医护人员中 SARS-CoV-2 的血清流行率。
Medicina (Kaunas). 2021 Feb 6;57(2):148. doi: 10.3390/medicina57020148.
2
Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers.新冠病毒血清学检测的验证和无症状医护人员的大规模筛查。
Clin Biochem. 2021 Apr;90:23-27. doi: 10.1016/j.clinbiochem.2021.01.004. Epub 2021 Jan 17.
3
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.新型冠状病毒血清学检测方法在 SARS-CoV-2 感染和 COVID-19 诊断中的研究进展。
Front Public Health. 2021 Feb 18;8:620222. doi: 10.3389/fpubh.2020.620222. eCollection 2020.
4
Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.通过快速诊断免疫分析检测 COVID-19 患者的 SARS-CoV-2 特异性抗体。
Virol J. 2021 Mar 9;18(1):52. doi: 10.1186/s12985-021-01530-2.
5
Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.接触 SARS-CoV-2 疫情的医院工作人员的症状和免疫球蛋白发展情况。
Pediatr Allergy Immunol. 2020 Oct;31(7):841-847. doi: 10.1111/pai.13278. Epub 2020 Jun 18.
6
Comparative analysis of three point-of-care lateral flow immunoassays for detection of anti-SARS-CoV-2 antibodies: data from 100 healthcare workers in Brazil.巴西 100 名医护人员的研究数据:三种即时侧向流动免疫分析法检测抗 SARS-CoV-2 抗体的比较分析。
Braz J Microbiol. 2021 Sep;52(3):1161-1165. doi: 10.1007/s42770-021-00498-z. Epub 2021 Apr 19.
7
Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.五种用于 SARS-CoV-2 抗体诊断的免疫分析方法在真实临床常规检测环境中的临床诊断性能评估。
Pan Afr Med J. 2021 May 3;39:3. doi: 10.11604/pamj.2021.39.3.26471. eCollection 2021.
8
Clinical validation of an immunochromatographic SARS-Cov-2 IgM/IgG antibody assay with Japanese cohort.一种免疫层析法 SARS-CoV-2 IgM/IgG 抗体检测试剂盒的临床验证:来自日本队列的数据。
J Med Virol. 2021 Jan;93(1):569-572. doi: 10.1002/jmv.26363. Epub 2020 Aug 26.
9
Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection.感染后 13 个月 SARS-CoV-2 特异性抗体的持续存在。
Viruses. 2021 Nov 19;13(11):2313. doi: 10.3390/v13112313.
10
Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.弥补 COVID-19 诊断检测中的血清学差距:抗 SARS-CoV-2 IgA 抗体的价值。
J Med Virol. 2021 Mar;93(3):1436-1442. doi: 10.1002/jmv.26422. Epub 2020 Aug 21.

引用本文的文献

1
The causal relationship model of factors influencing COVID-19 preventive behaviors during the post-pandemic era and implications for health prevention strategies: a case of Bangkok City, Thailand.后疫情时代影响 COVID-19 预防行为因素的因果关系模型及对卫生预防策略的启示:以泰国曼谷市为例。
BMC Infect Dis. 2024 Aug 29;24(1):887. doi: 10.1186/s12879-024-09818-8.
2
Consequences of COVID-19 and Its Variants: Understanding the Physical, Oral, and Psychological Impact.新冠病毒及其变体的后果:了解其对身体、口腔和心理的影响。
Int J Environ Res Public Health. 2023 Feb 10;20(4):3099. doi: 10.3390/ijerph20043099.
3
SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis.全球范围内 SARS-CoV-2 血清流行率:一项更新的系统评价和荟萃分析。
Eur J Med Res. 2022 Jun 2;27(1):81. doi: 10.1186/s40001-022-00710-2.
4
Non-linear transformation of enzyme-linked immunosorbent assay (ELISA) measurements allows usage of linear models for data analysis.酶联免疫吸附测定(ELISA)测量的非线性变换允许使用线性模型进行数据分析。
Virol J. 2022 May 18;19(1):85. doi: 10.1186/s12985-022-01804-3.

本文引用的文献

1
Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries.八个国家儿科医疗机构医护人员中 SARS-CoV-2 抗体的横断面患病率。
J Hosp Infect. 2021 Apr;110:60-66. doi: 10.1016/j.jhin.2020.12.019. Epub 2021 Jan 7.
2
Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use.六种市售 SARS-CoV-2 抗体检测试剂盒的比较——检测试剂盒的选择取决于预期用途。
Int J Infect Dis. 2021 Feb;103:381-388. doi: 10.1016/j.ijid.2020.12.017. Epub 2020 Dec 10.
3
Virology, transmission, and pathogenesis of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的病毒学、传播与发病机制
BMJ. 2020 Oct 23;371:m3862. doi: 10.1136/bmj.m3862.
4
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.瑞典医护人员中的 SARS-CoV-2 暴露、症状和血清流行率。
Nat Commun. 2020 Oct 8;11(1):5064. doi: 10.1038/s41467-020-18848-0.
5
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.五种 SARS-CoV-2 免疫测定法的性能特征:头对头基准比较。
Lancet Infect Dis. 2020 Dec;20(12):1390-1400. doi: 10.1016/S1473-3099(20)30634-4. Epub 2020 Sep 23.
6
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.SARS-CoV-2 血清流行率和医护人员无症状病毒携带情况:一项横断面研究。
Thorax. 2020 Dec;75(12):1089-1094. doi: 10.1136/thoraxjnl-2020-215414. Epub 2020 Sep 11.
7
COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes.医护人员中的 COVID-19:一项针对患病率、风险因素、临床特征和结局的实时系统评价和荟萃分析。
Am J Epidemiol. 2021 Jan 4;190(1):161-175. doi: 10.1093/aje/kwaa191.
8
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.四种血清学检测方法在不同人群血清样本中检测抗 SARS-CoV-2 抗体的比较。
Sci Transl Med. 2020 Sep 2;12(559). doi: 10.1126/scitranslmed.abc3103. Epub 2020 Aug 17.
9
Risk of COVID-19 in health-care workers in Denmark: an observational cohort study.丹麦医护人员感染 COVID-19 的风险:一项观察性队列研究。
Lancet Infect Dis. 2020 Dec;20(12):1401-1408. doi: 10.1016/S1473-3099(20)30589-2. Epub 2020 Aug 3.
10
Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study.英国医护人员即时血清学检测对迟发性 SARS-CoV-2 病例的识别作用:一项前瞻性多中心队列研究。
Lancet Respir Med. 2020 Sep;8(9):885-894. doi: 10.1016/S2213-2600(20)30315-5. Epub 2020 Jul 24.